Scientists from Rice University in the US are close to creating a new device to detect and treat cancer. This implantable device will be used to deliver drugs into the body and destroy cancer cells. In this respect reports TimesNewsUK.
The hybrid molecular production regulator, or HAMMR, is a device equipped with sensors that monitor rapidly mutating cancer cells and adjust the release of immunotherapy drugs based on the patient’s response. The attending physician determines what medications the patient needs, then the medication is injected into a device that will then be implanted in the abdominal cavity. The device is intended for short-term use (up to 60 days) and is charged outside the human body.
Researchers said the new technology could improve treatment outcomes for difficult-to-treat cancers such as ovarian and pancreatic cancer.
Bioengineer Omid Weise, who led the research, noted that similar devices have already been developed to treat diabetes. Some people use an insulin pump, a device that continuously delivers insulin under the skin.
The scientists also added that the device will help monitor how cancer cells change in real time. It is possible for HAMMR to send the received data to a smartphone.
previously scientist explainedHow human behavior affects cancer treatment.
Source: Gazeta
Barbara Dickson is a seasoned writer for “Social Bites”. She keeps readers informed on the latest news and trends, providing in-depth coverage and analysis on a variety of topics.